BE699828A - - Google Patents

Info

Publication number
BE699828A
BE699828A BE699828DA BE699828A BE 699828 A BE699828 A BE 699828A BE 699828D A BE699828D A BE 699828DA BE 699828 A BE699828 A BE 699828A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE699828A publication Critical patent/BE699828A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE699828D 1964-06-17 1967-06-13 BE699828A (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25161/64A GB1072355A (en) 1964-06-17 1964-06-17 Antiseptic and anti-pruretic solution containing camphor

Publications (1)

Publication Number Publication Date
BE699828A true BE699828A (xx) 1967-12-13

Family

ID=10223217

Family Applications (1)

Application Number Title Priority Date Filing Date
BE699828D BE699828A (xx) 1964-06-17 1967-06-13

Country Status (5)

Country Link
AU (1) AU417461B2 (xx)
BE (1) BE699828A (xx)
DE (1) DE1617524A1 (xx)
FR (1) FR6548M (xx)
GB (1) GB1072355A (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181007A (en) * 1981-02-23 1985-01-15 Herbert Lapidus Antipruritic compositions
WO1994000108A1 (en) * 1992-06-19 1994-01-06 The Procter & Gamble Company Topical aromatic releasing compositions
FR2725901B1 (fr) * 1994-10-25 1997-06-27 Thorel Jean Noel Utilisation du calcium en cosmetologie dans le traitement local des phenomenes irritatifs
DE69533842T2 (de) * 1994-12-21 2006-02-16 Cosmederm Technologies, La Jolla Formulierungen und verfahren zur verminderung von hautirritationen
WO1996019182A1 (en) * 1994-12-21 1996-06-27 Cosmederm Technologies Formulations and methods for reducing skin irritation
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
FR2732602B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p

Also Published As

Publication number Publication date
FR6548M (xx) 1968-12-16
GB1072355A (en) 1967-06-14
AU2303567A (en) 1968-12-19
DE1617524A1 (de) 1971-04-08
AU417461B2 (en) 1971-09-21

Similar Documents

Publication Publication Date Title
FR6548M (xx)
AU442366B2 (xx)
BE554195A (xx)
BE507097A (xx)
BE432268A (xx)
BE47396A (xx)
BE483969A (xx)
BE518974A (xx)
BE564626A (xx)
BE584699A (xx)
BE603534A (xx)
BE610935A (xx)
BE613833A (xx)
BE621510A (xx)
BE622126A (xx)
BE623398A (xx)
BE626083A (xx)
BE626684A (xx)
BE627057A (xx)
BE627390A (xx)
BE627931A (xx)
BE628611A (xx)
BE629793A (xx)
BE632875A (xx)
BE636791A (xx)